揭开免疫机制和治疗点在肺腺性转化中的免疫机制和治疗点
Haiyan Xu1, Ying Yang2, PingLi Wang3
1Department of Biobank, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Frontiers in immunology
|June 26, 2025
概括
腺癌转变为状细胞癌 (AST) 导致耐药性,并影响肺癌免疫治疗. 了解AST期间瘤免疫微环境 (TIME) 变化对于改善非小细胞肺癌 (NSCLC) 治疗至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 在肺腺癌 (LUAD) 中,腺癌转化为状细胞癌 (AST) 与耐药性和不良结果有关.
- 在AST期间瘤免疫微环境 (TIME) 的变化会影响免疫治疗的疗效.
- 在AST中异常驱动基因表达重塑免疫细胞透和功能.
研究的目的:
- 系统地审查ADENOSQUAMUS CARCINOMA分化期间的TIME变化.
- 阐明AST相关的免疫变化背后的分子调节机制.
- 探索组合免疫疗法在非小细胞肺癌 (NSCLC) 治疗中的潜力.
主要方法:
- 在LUAD中对AST,TIME和免疫治疗研究的文献综述.
- 对驱动免疫细胞在转基因分化过程中的变化的分子机制的分析.
- 综合发现,以评估与AST相关的NSCLC的免疫治疗潜力.
主要成果:
- AST显著改变了 TIME,影响了免疫细胞的组成和功能.
- 参与AST的特定驱动基因有助于免疫逃避和炎症.
- 了解这些TIME动态是预测治疗反应的关键.
结论:
- AST诱导的 TIME 变化对当前的疗法构成了挑战.
- 针对AST中的分子通路可能会恢复抗瘤免疫力.
- 组合免疫疗法有望改善AST的NSCLC患者的治疗结果.
更多相关视频
相关概念视频
01:51Mechanisms of Retrovirus-induced Cancers
5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K